Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Chemo-Radiation-Induced Abscopal Effect in Metastatic Breast Cancer and in Other Metastatic Sites of Solid Tumors

NCT02474186 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02474186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02474186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Chemo-Radiation-Induced Abscopal Effect in Metastatic Breast Cancer and in Other Metastatic Sites of Solid Tumors
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
July 31, 2015
Enrollment
41 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic breast cancer, solid tumor